Self-reported efficacy and safety of infliximab and adalimumab biosimilars after non-medical switch in patients with inflammatory bowel disease: results of a multicenter survey

.

Source: Expert Opinion on Biological Therapy - May 10, 2023 Category: Drugs & Pharmacology Authors: Patr ícia Sarlós Alexander Bikar Nelli Farkas Tam ás Resál Zolt án Szepes Klaudia Farkas Ferenc Nagy Áron Vincze Pal Miheller Tam ás Molnár Source Type: research